drugset / Trial / NCT05297695

Helicobacter Pylori Eradication Therapy for Epileptic Children

NCT05297695 ↗

Phase 2/3 Completed 126 enrolled Sohag University
RandomizedParallel-groupSingle-blindTreatment

Summary

Helicobacter pylori (H. pylori) infection is associated with several health problems. The role of H. pylori infection in epilepsy has been investigated in a few studies. To the best of our knowledge, there have been no previous studies on the effect of treating H. pylori infection on seizure frequency among children with drug-resistant idiopathic generalized epilepsy. This study aims to evaluate the effect of treating H. pylori infection on seizure frequency among children with drug-resistant idiopathic generalized epilepsy.

Timeline

Start
2022-04-20
Primary completion
2023-10-10
Completion
2023-12-30

Outcome

Met primary endpoint

paper Seizure improvement occurred in 23 (33%) children in the study group compared with seven (12%) children in the comparison group PMID 40247384 ↗

paper (Risk ratio [RR] 2.7, 95% confidence interval [CI]: 1.3-5.9; p 0.006). PMID 40247384 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified — —
Subject Clarithromycin Small molecule — —
Subject Esomeprazole Small molecule — —